Ceftolozane/tazobactam therapy of respiratory infections due to multidrug-resistant pseudomonas aeruginosa

Research output: Contribution to journalLetter

31 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)853-855
Number of pages3
JournalClinical Infectious Diseases
Volume61
Issue number5
DOIs
StatePublished - Jan 1 2015

Fingerprint

Drug Resistance, Multiple, Bacterial
Penicillanic Acid
Ventilator-Associated Pneumonia
Pseudomonas Infections
Microbial Sensitivity Tests
Cephalosporins
Respiratory Tract Infections
Pseudomonas aeruginosa
Anti-Bacterial Agents
Therapeutics
tazobactam drug combination ceftolozane

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{2c6114cdc4924c3b9a5708df0aa8d79c,
title = "Ceftolozane/tazobactam therapy of respiratory infections due to multidrug-resistant pseudomonas aeruginosa",
author = "Michael Gelfand and Kerry Cleveland",
year = "2015",
month = "1",
day = "1",
doi = "10.1093/cid/civ411",
language = "English (US)",
volume = "61",
pages = "853--855",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Ceftolozane/tazobactam therapy of respiratory infections due to multidrug-resistant pseudomonas aeruginosa

AU - Gelfand, Michael

AU - Cleveland, Kerry

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84942018581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942018581&partnerID=8YFLogxK

U2 - 10.1093/cid/civ411

DO - 10.1093/cid/civ411

M3 - Letter

VL - 61

SP - 853

EP - 855

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 5

ER -